19º Congreso de la Sociedad Española de Química Terapéutica

  • es
  • en
  • Home

    ATTENTION: Deadline for abstract submission and early registration extended.

    New deadline abstract submission: April 30th

    Newdeadline early registration: May 10th


    Second communication (download here):

    SEQT, the Spanish member of the European Federation for Medicinal Chemistry (EFMC), is organizing the 19th National Meeting “New challenges in drug discovery”, to be held in the Faculty of Pharmacy of the University of the Basque Country, Vitoria-Gasteiz (Spain) on July 8-11, 2019.

    The scientific program will include both plenary and invited lectures as well as short oral communications and flash presentations, covering the main stages of drug discovery and development (provisional programme is shown on our web site www.congresoseqt2019.es).


    Confirmed speakers to date

    • Ignacio Alfonso (IQAC-CSIC, España).

    “Supramolecular approaches to Chemical Biology”

    • José Ignacio Andrés (Janssen Research & Development, Toledo, Spain)

    “Chemical Biology and Proteomics in Drug Discovery: Beyond Target identification and Target Validation”

    • Gonçalo L. Bernardes (University of Cambridge, UK)

    “Chemical Physiology of Antibody Conjugates and Natural Products”.

    • Maria Laura Bolognesi (University of Bologna, Italy)

    “Harnessing polypharmacology with medicinal chemistry in Alzheimer’s disease drug discovery”

    • Erick M. Carreira (ETH, Zurich, Switzerland)

    “Discovery and Surprises with Natural Products and their Connection to Human Biology”

    • Kristof van Emelen (ProDigest BVBA, Ghent, Belgium)

    “DNA-encoded libraries: key principles and what (not) to expect from them”

    • Benoit Gauthier (CABIMER, Seville, Spain)

    “LRH-1/NR5A2 a novel drug target for Diabetes therapeutics”

    • Yvette van Kooyk (University of Amsterdam, The Netherlands)

    “Glycocode of the tumor microenvironment. A novel immune check-point”

    • Luis M. Liz-Marzán (CIC Biomagune, San Sebastián, Spain)

    “Diagnosis and Therapy Based on Gold Nanoparticles”

    • Catherine Llorens- Cortes (CIRB, Collège de France, Paris, France).

    ”Central-Acting Amino-peptidase A Inhibitors for new Treatment of Hypertension. From Discovery to Clinical Trial”

    • Modesto J. Remuiñan (GlaxoSmithKline, Tres Cantos, Spain)

    “Teaching new tricks to an old dog: reprograming Ethionamide to fight Multidrug Resistant Tuberculosis”

    • Gianluca Sbardella (University of Salerno, Italy)

    “Sympathy for the methyl: a library-on-library screening approach to identify small-molecule ligands of methyl-lysine reader proteins”



    Call for abstracts

    Scientists interested in participating with a short oral communication (15 min) or flash presentation (5 min) can send an abstract before April 12th, 2019, using the Abstract template available on the meeting website. Accepted communications will be notified before registration deadline.



    Registration form must be completed on our web site. Early registration will be available until April 30th, 2019. The payment receipt must be sent at the time of registration. Fees are as follows*:


    Payment date

    Until April 30th

    (Extended, May 10th)

    After April 30th

    (Extended, May 10th)

    SEQT members  (or EFMC Adhering Organization) 400 € 500 €
    Young SEQT members (<35) 250 € 300 €
    Non members 500 € 600 €
    Young non members (<35) 300 € 350 €

    * Registration fee includes Welcome cocktail, lunches on 9th 10th and 11th and Meeting dinner


    Sociedad Española de Química Terapéutica. Banco Sabadell, CEISS IBAN: ES16 0081 4313 4200 0116 6819 ABA/Swift: BSABESBB


    For further information and regular updates, visit our website: www.congresoseqt2019.es

    e-mail: contacto.congresoseqt@ehu.es